PATHOCIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pathocil, and what generic alternatives are available?
Pathocil is a drug marketed by Wyeth Ayerst and is included in two NDAs.
The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pathocil
A generic version of PATHOCIL was approved as dicloxacillin sodium by TEVA on June 3rd, 1982.
Summary for PATHOCIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Patent Applications: | 1,085 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PATHOCIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PATHOCIL
US Patents and Regulatory Information for PATHOCIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | PATHOCIL | dicloxacillin sodium | CAPSULE;ORAL | 050011-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | PATHOCIL | dicloxacillin sodium | CAPSULE;ORAL | 050011-003 | Mar 28, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | PATHOCIL | dicloxacillin sodium | FOR SUSPENSION;ORAL | 050092-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |